Cardea Bio Completes Planned Launch of CRISPR QC™

April 05, 2022 11:02 AM Eastern Daylight Time SAN DIEGO–(BUSINESS WIRE)–Today, Cardea Bio, Inc. – the world’s only mass producer of biocompatible semiconductors – announced a significant milestone with the launch of CRISPR QC™ Inc. as a separate business using Cardea’s CRISPR-Chip™ technology for a range of quality control services for CRISPR gene editing. This […]